Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Schizophrenia (Heidelberg, Germany)
|
November 25, 2025
Why is schizophrenia a huge graveyard of molecules?
Eduard Parellada, Patricia Gassó
Translational Psychiatry
|
May 7, 2021
Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia
Eduard Parellada, Patricia Gassó
Pharmacogenomics
|
November 12, 2015
Applicability of gene expression and systems biology to develop pharmacogenetic predictors; antipsychotic-induced extrapyramidal symptoms as an example
Sergi Mas, Patricia Gassó, Amelia Lafuente
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 23, 2012
Functional analysis of gene expression in risperidone treated cells provide new insights in molecular mechanism and new candidate genes for pharmacogenetic studies
Sergi Mas, Patricia Gassó, Miquel Bernardo, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
May 8, 2014
Influence of ABO genotype and phenotype on angiotensin-converting enzyme plasma activity
Patricia Gassó, Marie A Ritter, Sergi Mas, et al.
Fundamental & Clinical Pharmacology
|
September 20, 2011
Sulforaphane protects SK-N-SH cells against antipsychotic-induced oxidative stress
Sergi Mas, Patricia Gassó, Gemma Trias, et al.
Journal of Psychiatric Research
|
October 17, 2013
Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients
Patricia Gassó, Sergi Mas, Oriol Molina, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 1, 2011
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells
Patricia Gassó, Sergi Mas, Oriol Molina, et al.
Medicina Clinica
|
December 20, 2008
[Effect of polymorphisms of the cathecol-O-methyltransferase on schizophrenia risk in a Spanish population]
Sergi Mas, Patricia Gassó, Anna Crescenti, et al.
Clinical and Experimental Pharmacology & Physiology
|
March 19, 2008
Cyp2d6*3, *4, *5 and *6 polymorphisms and antipsychotic-induced extrapyramidal side-effects in patients receiving antipsychotic therapy
Anna Crescenti, Sergi Mas, Patricia Gassó, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Schizophrenia (Heidelberg, Germany)
|
November 25, 2025
Why is schizophrenia a huge graveyard of molecules?
Eduard Parellada, Patricia Gassó
Translational Psychiatry
|
May 7, 2021
Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia
Eduard Parellada, Patricia Gassó
Pharmacogenomics
|
November 12, 2015
Applicability of gene expression and systems biology to develop pharmacogenetic predictors; antipsychotic-induced extrapyramidal symptoms as an example
Sergi Mas, Patricia Gassó, Amelia Lafuente
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 23, 2012
Functional analysis of gene expression in risperidone treated cells provide new insights in molecular mechanism and new candidate genes for pharmacogenetic studies
Sergi Mas, Patricia Gassó, Miquel Bernardo, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
May 8, 2014
Influence of ABO genotype and phenotype on angiotensin-converting enzyme plasma activity
Patricia Gassó, Marie A Ritter, Sergi Mas, et al.
Fundamental & Clinical Pharmacology
|
September 20, 2011
Sulforaphane protects SK-N-SH cells against antipsychotic-induced oxidative stress
Sergi Mas, Patricia Gassó, Gemma Trias, et al.
Journal of Psychiatric Research
|
October 17, 2013
Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients
Patricia Gassó, Sergi Mas, Oriol Molina, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 1, 2011
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells
Patricia Gassó, Sergi Mas, Oriol Molina, et al.
Medicina Clinica
|
December 20, 2008
[Effect of polymorphisms of the cathecol-O-methyltransferase on schizophrenia risk in a Spanish population]
Sergi Mas, Patricia Gassó, Anna Crescenti, et al.
Clinical and Experimental Pharmacology & Physiology
|
March 19, 2008
Cyp2d6*3, *4, *5 and *6 polymorphisms and antipsychotic-induced extrapyramidal side-effects in patients receiving antipsychotic therapy
Anna Crescenti, Sergi Mas, Patricia Gassó, et al.
Page
of 9